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Summary
Objectives: We report a clinical and genetic study of three consanguineous Tunisian families
affected by Pendred syndrome.
Patients and methods: Three families from the south of Tunisia were identiﬁed as affected by
Pendred syndrome. The patients and their families underwent ENT and general examination
and audiovestibular and radiological tests. Molecular DNA analysis was performed by the Sfax
Human Molecular Genetics Department.
Results: Forty-three patients (mean age: 21 years [2—60 years]) were affected. Tonal audiom-
etry showed bilateral sensorineural hearing loss in 87.5% of cases, and mixed hearing loss in
12.5% with bilateral high frequency sensorineural hearing loss and conductive hearing loss at
lower frequencies. Deafness was severe in 21% and profound in 79% of cases. Thyroid goiter
was found in 46.5% of cases. Inner ear CT scan found enlarged bilateral vestibular aqueducts
in all cases. Hormone analysis was normal and perchlorate test negative in all cases. A single
Pendred syndrome (PDS) gene mutation, L445W, was found.
Discussion: Pendred syndrome is the most frequent congenital deafness syndrome. It is char-
acterized by great intrafamilial phenotype variability.
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IntroductionPendred syndrome (PS), associating sensorineural hearing
loss, inner ear bone malformation and thyroid goiter, is the
most frequent of congenital deafness syndromes. It is a clin-
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cally and genetically heterogeneous recessive autosomal
enetic disorder.
Few studies worldwide, and none so far in Tunisia, have
nalyzed its clinical characteristics. A relationship between
poradic goiter and hearing loss was ﬁrst mentioned in
824 [1], but Pendred ﬁrst suggested its familial nature
n 1896, on the basis of an observation of two deaf-mute
isters with pronounced goiter [2]. Morgans and Trotter,
n 1958 [3], and Fraser, in 1965 [4], showed partial thy-
oxin synthesis deﬁcit in organic incorporation of iodine
o underlie the goiter formation. The PDS gene (Pendred
yndrome gene), now known as SLC26A4, is involved in
.
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she genesis of PS, with more than 140 mutations currently
escribed.
We report a clinical and genetic study of three carrier
amilies, from southern Tunisia.
atients and methods
linical study
he Sfax ENT team’s study of familial hearing loss was
ssentially based on ﬁeldwork with affected families. In
ach mission, the team comprised two ENT physicians, two
eneticists and one cochleovestibular exploration techni-
ian. Three families in southern Tunisia were thus identiﬁed
s PS carriers.
Interview ruled out acquired hearing loss and detailed
ach family’s history of hearing impairment, with clinical
nd evolutive characteristics, and drew up family trees.
linical ENT examination of all family members comprised
toscopy and vestibular, mouth cavity and dental, rhinolog-
cal, cervical and general examination.
Auditory exploration comprised pure tone audiometry
PTA) via headphones at 250, 500, 1000, 2000 and 4000Hz
o determine hearing loss frequency, threshold and Rinne;
ean hearing threshold and mean Rinne were calculatedor both ears.
Vestibular exploration comprised bithermal caloric test
sing water at 30◦ and 40◦C, with results displayed on a
reyss’ graph; reﬂectivity, valence and preponderance were
alculated.
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Figure 1 Genealogical treeI. Charfeddine et al.
Certain family members were admitted to our depart-
ent for complementary cochleovestibular, biological and
T exploration.
enetic study
NA molecular analysis was performed by the Sfax human
olecular genetics team.
esults
linical results
hree carrier families were identiﬁed, in the Ben Guerdène
nd Tataouine governorates of southern Tunisia. The total
umber of affected subjects was 43, with a mean age of
1 years (range: 2—60 years) and 18.6% under the age of
0 years. The sex ratio was 0.65 (predominantly female).
ig. 1 presents the genealogical trees of the three families.
Neck palpation found goiter in 46.5% of cases: diffuse in
8% and nodular in 42%. 62.5% of the under 10-year-olds had
iffuse thyroid goiter. Eighty percent of the nodular goiters
ere in patients over 30 years of age.
PTA was performed in 40 cases and found bilateral per-
eptual hearing loss in 87.5% of cases; the remaining 12.5%
howed mixed, predominantly bilateral sensorineural hear-
ng loss, with a mean Rinne of 25 dB (range: 10—40 dB).
earing loss was symmetric in 85% of cases (n = 34), severe
n 21% and profound in 79% (Fig. 2). Onset was very early
nd always severe or profound. All and especially high fre-
uencies were involved, without any obvious ﬂuctuation.
s of the three families.
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Caloric examination was performed in 19 cases and found
vestibular hyporeﬂexivity in 47%, areﬂexivity in 42% and
directional preponderance in one case. Only one of the 19
patients had normal results.
Inner ear CT scan was performed in eight cases and
found bilateral vestibular aqueduct enlargement in all eight
(Fig. 3).
Hormone assessment and thyroid scans were normal. Per-
chlorate test was performed in eight cases, all negative.
Genetic results
A single PDS gene mutation was found systematically in the
three families: L445W, a thymine to guanine transversion in
exon 11 at position 1558 (1558 T→G). The relevance of this
mutation has been demonstrated.
Discussion
More than 300 genetic syndromes involving hearing loss have
now been described [5]. With an incidence of 7—10/100,000
births [6], PS accounts for 2 to 10% of cases of hearing loss
syndrome. To the best of our knowledge, incidence has not
been speciﬁed for North Africa, Africa or the Arab countries.
Clinically, PS associates sensorineural hearing loss and
goiter, with wide phenotype variability.Hearing loss is typically cochlear, prelingual or early
postlingual, with various evolutions. It may be immediate
[1] or evolve in sudden steps followed by partial recovery,
as in ﬂuctuating hearing loss [7]. According to Boniver [1],
Figure 3 Inner ear CT scan: bilateral vestibular aqueduct
enlargement.
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t is typically perceptual and predominantly high-frequency;
ccording to other authors, it is mixed, with perceptual pre-
ominance and a transmissional low-frequency component
8,9]. The present series presented two types of audiometric
urve: pure perceptual hearing loss predominating at high-
requencies (87.5%), or mixed with low-frequency Rinne
12.5%). In terms of evolution, in the present series hearing
oss was permanent, with no signs of ﬂuctuation or stepwise
eterioration. Onset was very early and immediately severe
r profound in all cases.
Several authors reported clinical signs of vestibular
nvolvement [7,10], while others reported normal vestibu-
ar function [1]. In the present series, no patients showed
estibular signs although the caloric test was normal in only
ne case, showing vestibular hyporeﬂexivity in 47% of cases,
reﬂexivity in 42% and directional preponderance in one
ase.
Eighty percent of cases showed abnormal inner ear mor-
hology, almost always in the form of enlarged vestibular
queduct or Mondini dysplasia [11]. Johnsen et al. [12] found
ondini dysplasia in all of six inner ears of Pendred carriers.
oldfeld et al. [11], in a radiological study, found no superior
urn of the cochlea in 75% of cases, enlarged vestibular aque-
uct in 80%, and modiolus deﬁciency in 100%. For several
uthors, enlarged vestibular aqueduct is the characteristic
eature of PS, corresponding to a PDS gene mutation [10,13].
t is bilateral in 80% of cases [11]. In the present series, bilat-
ral enlarged vestibular aqueduct was found systematically.
Thyroid signs are highly variable, hindering the establish-
ent of diagnostic criteria [14]. Goiter is caused by iodine
ncorporation disorder with incomplete thyroxin synthesis
1], and prevalence is inversely proportional to daily iodine
ntake [15]. Onset is usually (63%) towards the end of the
rst decade or in young adulthood [16], but it can some-
imes be present at birth [1]. Both sexes are affected [16].
t is ﬁrst soft and diffuse, then hard and nodular [1] and
ometimes compressive [11]. In the present series, it was
ound in 62.5% of children under the age of 10 years.
Thyroid function is likewise variable. Hypothyroidism was
eported in 44 to 77% of goiters [16,17], sometimes at birth
18].
The perchlorate diagnostic test, introduced by Morgans
nd Trotter in 1958 [3], is based on salting out of non-
ncorporated radioactive iodine by perchlorate ions and
herefore reducing thyroid radioactivity following perchlo-
ate absorption. Results were systematically negative in the
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resent series, casting doubt on the test’s sensitivity and
peciﬁcity for PS. It also shows positive in Hashimoto thy-
oiditis, peroxidase deﬁciency and radioactive iodine-131
herapy [19], and has therefore given way to molecular and
enetic diagnosis for PS [20].
Hormone substitution is recommended in case of
ypothyroidism; total thyroidectomy is rarely indicated
15].
Histologically, no characteristic aspect has been identi-
ed, and no malign transformation reported [1].
The PDS gene or SLC26A4, underlying PS, lies in the 7q31
egion of chromosome7 and codes for pendrin, a 86-kDa
ransmembrane polypeptide containing 780 amino acids,
argely expressed in the inner ear and thyroid [21]. It is
ritical to endolymphatic ﬂuid homeostasis [22].
As well as PS, PDS gene mutation may cause DFNB4 con-
enital recessive deafness and enlarged vestibular aqueduct
yndrome. Only the thyroid goiter distinguishes the two
ypes of hearing loss, but intrafamilial variability in thyroid
nvolvement greatly hinders differential diagnosis.
More than 140 PDS mutations have been reported [13],
ach involving a different pendrin protein, with differing
etabolic and phenotypic impact [23]. Phenotypic variabil-
ty within a given family showing a single mutation, however,
emains to be explained, and may indicate the involvement
f other genetic factors [24].
In the present series, a single mutation, LW445 [25], also
eported in the Netherlands [26] and in Spain [27], was found
n all three families.
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